Beijing Beilu Pharmaceutical (300016.SZ) has obtained the "Drug Registration Certificate" for Iodinated Phochol Injection.

Beijing Beilu Pharmaceutical (300016.SZ) announced that it has recently received the Drug Registration Certificate for Iopamidol Injection issued by the National Medical Products Administration. Iopamidol Injection is a product of the original research enterprise Mallinckrodt in the United States, and it is indicated for: (1) coronary angiography and left ventricular angiography, aortic angiography, peripheral and visceral artery angiography in adults; (2) contrast-enhanced CT scans of the head and body, venous angiography, and excretory urography in adults; (3) cardiovascular angiography in children.